Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02320058 |
|---|---|
| Brief Title: | An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself (CheckMate204) |
| First Submitted : | December 16, 2014 |
| First Submitted that Met QC Criteria : | December 16, 2014 |
| First Posted : | December 19, 2014 (Estimate) |
| Results First Submitted : | September 8, 2021 |
| Results First Submitted that Met QC Criteria : | September 8, 2021 |
| Results First Posted : | October 5, 2021 |
| Last Update Submitted that Met QC Criteria : | September 8, 2021 |
| Last Update Posted : | October 5, 2021 |